These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 10800524)

  • 1. Kala-azar as an AIDS-related opportunistic infection.
    Murray HW
    AIDS Patient Care STDS; 1999 Aug; 13(8):459-65. PubMed ID: 10800524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010.
    Lima IP; Müller MC; Holanda TA; Harhay M; Costa CH; Costa DL
    Rev Soc Bras Med Trop; 2013; 46(2):156-60. PubMed ID: 23666663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kala-azar comes to New York.
    Parkas V; Godwin J; Murray HW
    Arch Intern Med; 1997 Apr; 157(8):921-3. PubMed ID: 9129553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.
    Agostoni C; Dorigoni N; Malfitano A; Caggese L; Marchetti G; Corona S; Gatti S; Scaglia M
    Infection; 1998; 26(2):93-9. PubMed ID: 9561378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug unresponsiveness & combination therapy for kala-azar.
    Jha TK
    Indian J Med Res; 2006 Mar; 123(3):389-98. PubMed ID: 16778318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS.
    Mastroianni A
    Infez Med; 2004 Sep; 12(3):197-204. PubMed ID: 15711134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visceral leishmaniasis as a threat for non-endemic countries].
    Górski S; Wiercińska-Drapało A
    Wiad Parazytol; 2009; 55(3):195-200. PubMed ID: 19856834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Visceral Leishmaniasis the same in HIV-coinfected adults?
    Henn GAL; Ramos Júnior AN; Colares JKB; Mendes LP; Silveira JGC; Lima AAF; Aires BP; Façanha MC
    Braz J Infect Dis; 2018; 22(2):92-98. PubMed ID: 29601790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-kala-azar dermal Leishmaniasis in two different clinical contexts.
    Barroso DH; Silva CE; Perdigao e Vasconcelos AC; Cavalcanti SM; Brito ME; Medeiros AC
    An Bras Dermatol; 2015; 90(3 Suppl 1):108-10. PubMed ID: 26312689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kala-azar in Uttar Pradesh--a study of 66 patients.
    Mittal V; Singh VK; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
    Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
    AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-kala-azar dermal leishmaniasis in HIV-infected patients with AIDS: a report of two cases diagnosed in the USA.
    Farooq U; Choudhary S; Chacon AH; Lebrun E; Shiman MI; Hernandez J; Milikowski C; Kerdel FA; Romanelli P
    Int J Dermatol; 2013 Sep; 52(9):1098-104. PubMed ID: 23834626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.